Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Philips reported Q4 2022 sales of EUR 5.4 billion, a 3% comparable sales growth driven by improved component supplies, despite ongoing supply chain challenges. Order intake decreased by 8%, primarily due to reduced demand for COVID-19-related products. Full-year sales fell to EUR 17.8 billion, a 3% decline, largely attributed to operational hurdles and geopolitical factors. Adjusted EBITA for Q4 was EUR 651 million (12% margin). The company anticipates low-single-digit sales growth and improved EBITA in 2023, while maintaining a dividend of EUR 0.85 per share. CEO Roy Jakobs emphasized efforts to enhance patient safety and quality management amidst challenging conditions.
The Michigan Department of Health and Human Services (MDHHS) has partnered with Royal Philips (NYSE: PHG) to enhance maternal and infant health in Michigan. The Philips Pregnancy+ mobile app, with over 55 million downloads, will be made accessible to Medicaid-eligible families, accounting for 45% of births in the state. This initiative aims to improve health outcomes by directing users to various state programs, such as home visiting services and breastfeeding resources. MDHHS expects this partnership to address access barriers in maternal care, particularly for underrepresented communities.
Royal Philips (NYSE: PHG) has received a perfect score of 5 out of 5 from Forbes Magazine for its Pregnancy+ Application, recognized in the list of the “Best Pregnancy Apps of 2023.” The app, with over 55 million downloads, provides personalized content and expert information to support parents from pregnancy onset through various stages. Forbes praised the app for its comprehensive features, including daily tailored articles and guides on breastfeeding and exercise. Philips remains a global leader in health technology, focusing on improving health outcomes with integrated solutions.
Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG) have announced an expansion of their partnership to enhance patient monitoring for home telehealth applications with the Masimo W1™ watch. This innovative technology will integrate Masimo's advanced health tracking with Philips's patient monitoring ecosystem, offering continuous, remote monitoring of vital health data. The combined solution aims to support early discharge initiatives and chronic illness management. The Masimo W1 is CE marked and awaiting FDA clearance. This development will be showcased at Arab Health 2023, highlighting advancements in telehealth.
Royal Philips (NYSE: PHG) announced an update regarding its subsidiary Philips Respironics' program addressing health risks linked to the foam in CPAP, BiPAP, and mechanical ventilator devices. The company confirmed that testing for first-generation DreamStation devices is complete, revealing that approximately 68% of these devices were not exposed to ozone cleaning as per usage instructions. Independent laboratories and external medical experts conducted the assessments, providing a comprehensive review.
Royal Philips (NYSE: PHG) has partnered with MagCorp to explore high-temperature superconducting MRI magnets that don't require helium cooling. This collaboration aims to enhance MRI accessibility and sustainability, potentially lowering costs while reducing environmental impact. The new technology could decrease the size and weight of MRI machines and expand patient access, especially in underserved areas. Philips has already introduced BlueSeal magnet technology, leading the market in helium-free MRI solutions. The partnership focuses on developing superconductors that operate at higher temperatures and are based on more abundant materials.
On November 28, 2022, Philips unveiled its next-generation Advanced Visualization Workspace at the RSNA annual meeting in Chicago. This platform features new cardiac MR Suite workflows, AI-powered CT ASPECT Scoring, and enhanced CT Liver Analysis applications. It aims to integrate diagnostics across multiple specialties, improving clinical efficiency and diagnostic accuracy. With over 70 applications, the workspace supports real-time analysis and communication, enhancing patient care. Philips also introduced a new Radiology Information System that streamlines departmental workflows and patient scheduling.
Royal Philips announced the launch of its new Ultrasound Compact System 5000 Series at the RSNA annual meeting. This portable ultrasound solution offers premium imaging quality comparable to larger systems while enhancing usability for both novice and advanced users. Features include compatibility with existing Philips systems, an optional battery for up to 2.5 hours of scanning, and integration with Philips Collaboration Live for telemedicine support. The system aims to improve patient outcomes by providing on-site diagnostic capabilities, thereby streamlining workflows and enhancing patient experience.
Royal Philips (NYSE: PHG) showcased its innovative health technology solutions at the RSNA annual meeting, aimed at enhancing radiology workflows. Addressing the increasing data volume and staff burnout in radiology, the company presented AI-powered systems to improve operational efficiency and patient care. Key highlights include the launch of the Philips Imaging Orchestrator and advancements in AI-enabled image interpretation. Philips emphasizes a commitment to sustainable diagnostic infrastructure, promising better health outcomes and lower care costs. The company generated EUR 17.2 billion in sales in 2021.
Philips Norelco has launched Shavetopia, an interactive hub on Roblox where users can purchase facial hairstyles for their avatars. This initiative supports Movember, with proceeds aiding men's health causes. Users can try on different styles and earn bonuses through mini-games. The program runs until November 30, 2022, and includes a $400,000 donation to Movember. Philips Norelco also pledges additional donations through product sales, contributing to mental health awareness and prostate cancer initiatives.